Two Sigma Investments
QNCX icon

Two Sigma Investments’s Quince Therapeutics QNCX Stock Holding History

Two Sigma Investments’s Portfolio QNCX Stock Details QNCX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.22K Sell
356
-549
-61% -$110K ﹤0.01% 4537
2025
Q4 		$606K Buy
905
+830
+1,107% +$418K ﹤0.01% 3205
2025
Q3 		$24.6K Sell
75
-12
-14% -$4K ﹤0.01% 3587
2025
Q2 		$28.7K Sell
87
-119
-58% -$27.2K ﹤0.01% 3101
2025
Q1 		$54.7K Buy
206
+54
+36% +$16.5K ﹤0.01% 3035
2024
Q4 		$56.7K Buy
+152
New +$45.7K ﹤0.01% 3031
2024
Q1 		– Sell
-66
Closed -$13.8K – 3319
2023
Q4 		$13.8K Sell
66
-32
-33% -$6.41K ﹤0.01% 3065
2023
Q3 		$22K Sell
98
-250
-72% -$65.3K ﹤0.01% 2866
2023
Q2 		$105K Sell
348
-287
-45% -$89.3K ﹤0.01% 2753
2023
Q1 		$198K Sell
635
-1,701
-73% -$333K ﹤0.01% 2558
2022
Q4 		$298K Sell
2,336
-152
-6% -$25.4K ﹤0.01% 2251
2022
Q3 		$662K Sell
2,488
-64
-3% -$24.4K ﹤0.01% 1646
2022
Q2 		$1.13M Buy
2,552
+171
+7% +$121K ﹤0.01% 1490
2022
Q1 		$2.95M Sell
2,381
-606
-20% -$825K 0.01% 1173
2021
Q4 		$7.54M Buy
2,987
+2,622
+718% +$16M 0.02% 952
2021
Q3 		$6.7M Buy
365
+184
+102% +$2.93M 0.02% 1015
2021
Q2 		$1.92M Sell
181
-7
-4% -$58.7K ﹤0.01% 1907
2021
Q1 		$1.35M Buy
188
+86
+84% +$619K ﹤0.01% 2038
2020
Q4 		$564K Buy
102
+39
+62% +$346K ﹤0.01% 2425
2020
Q3 		$627K Buy
63
+9
+17% +$81.9K ﹤0.01% 2071
2020
Q2 		$501K Buy
+54
New +$495K ﹤0.01% 1993

Other funds holding QNCX

WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.5B AUM 75.26% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Two Sigma Investments's QNCX Position: Q1 2026 in Review

Two Sigma Investments reduced its Quince Therapeutics (QNCX) stake by 61% in Q1 2026, selling an estimated $110K and leaving 356 shares worth $7.22K. The position accounts for ﹤0.01% of the portfolio, ranked #4537.

Two Sigma Investments first reported a position in QNCX in Q2 2020 and has held it in 21 quarters since. The position peaked at $7.54M in Q4 2021. 43 funds tracked by Wall St. Rank hold QNCX as of Q1 2026.

  • Two Sigma Investments held 356 shares of Quince Therapeutics worth $7.22K as of Q1 2026.
  • Two Sigma Investments sold 549 Quince Therapeutics shares in Q1 2026, an estimated $110K.
  • Quince Therapeutics made up ﹤0.01% of Two Sigma Investments's portfolio in Q1 2026, its #4537 holding.
  • Two Sigma Investments first reported a position in Quince Therapeutics in Q2 2020 and has held it in 21 quarters since.
  • Two Sigma Investments's Quince Therapeutics position peaked at $7.54M in Q4 2021.
  • 43 funds tracked by Wall St. Rank held Quince Therapeutics as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.